HI
HSBIO index
ProductHeard in 1 episode across 1 show since Sep 2026
A market index tracking selected healthcare and biotechnology companies, particularly those listed in the relevant Asian equity market.
Episodes
1
across 1 show
First heard
Sep 2026
Expert statements
1
1 positive
Episodes per month
Public PodLume episodes featuring it, over the last year.
1
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 1 |
| Oct 2026 | 0 |
What experts have said about HSBIO index
1 statement · 1 positive
The HS Bio Index is materially outperforming a flat broader market.
“HS Bio materially outperforming a market that's flat”
Open the episode · Insilico Rises, Hygon Dips, AOU GainsListen at 1:30
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
1 episode featuring HSBIO index, newest first
